109 related articles for article (PubMed ID: 21297044)
1. Toward neurotrophin-based therapeutics.
Monteggia LM
Am J Psychiatry; 2011 Feb; 168(2):114-6. PubMed ID: 21297044
[No Abstract] [Full Text] [Related]
2. Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning.
Andero R; Heldt SA; Ye K; Liu X; Armario A; Ressler KJ
Am J Psychiatry; 2011 Feb; 168(2):163-72. PubMed ID: 21123312
[TBL] [Abstract][Full Text] [Related]
3. Amygdala BDNF signaling is required for consolidation but not encoding of extinction.
Chhatwal JP; Stanek-Rattiner L; Davis M; Ressler KJ
Nat Neurosci; 2006 Jul; 9(7):870-2. PubMed ID: 16783370
[TBL] [Abstract][Full Text] [Related]
4. Catalpol ameliorates beta amyloid-induced degeneration of cholinergic neurons by elevating brain-derived neurotrophic factors.
Wang Z; Liu Q; Zhang R; Liu S; Xia Z; Hu Y
Neuroscience; 2009 Nov; 163(4):1363-72. PubMed ID: 19635525
[TBL] [Abstract][Full Text] [Related]
5. Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging.
Zeng Y; Liu Y; Wu M; Liu J; Hu Q
J Alzheimers Dis; 2012; 31(4):765-78. PubMed ID: 22710915
[TBL] [Abstract][Full Text] [Related]
6. [Brain-derived neurotrophic factor and psychiatric diseases].
Kojima M
Tanpakushitsu Kakusan Koso; 2007 Jul; 52(8):900-5. PubMed ID: 17642274
[No Abstract] [Full Text] [Related]
7. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
8. 7,8,3'-Trihydroxyflavone, a potent small molecule TrkB receptor agonist, protects spiral ganglion neurons from degeneration both in vitro and in vivo.
Yu Q; Chang Q; Liu X; Gong S; Ye K; Lin X
Biochem Biophys Res Commun; 2012 Jun; 422(3):387-92. PubMed ID: 22575512
[TBL] [Abstract][Full Text] [Related]
9. Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear.
Choi DC; Maguschak KA; Ye K; Jang SW; Myers KM; Ressler KJ
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2675-80. PubMed ID: 20133801
[TBL] [Abstract][Full Text] [Related]
10. A novel natural product inspired scaffold with robust neurotrophic, neurogenic and neuroprotective action.
Chakravarty S; Maitra S; Reddy RG; Das T; Jhelum P; Kootar S; Rajan WD; Samanta A; Samineni R; Pabbaraja S; Kernie SG; Mehta G; Kumar A
Sci Rep; 2015 Sep; 5():14134. PubMed ID: 26388493
[TBL] [Abstract][Full Text] [Related]
11. 7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways.
Tsai T; Klausmeyer A; Conrad R; Gottschling C; Leo M; Faissner A; Wiese S
Mol Cell Neurosci; 2013 Sep; 56():18-28. PubMed ID: 23500004
[TBL] [Abstract][Full Text] [Related]
12. Activation of BDNF signaling prevents the return of fear in female mice.
Baker-Andresen D; Flavell CR; Li X; Bredy TW
Learn Mem; 2013 Apr; 20(5):237-40. PubMed ID: 23589089
[TBL] [Abstract][Full Text] [Related]
13. Neurobiological effects of the green tea constituent theanine and its potential role in the treatment of psychiatric and neurodegenerative disorders.
Lardner AL
Nutr Neurosci; 2014 Jul; 17(4):145-55. PubMed ID: 23883567
[TBL] [Abstract][Full Text] [Related]
14. Modulatory effects of the novel TrkB receptor agonist 7,8-dihydroxyflavone on synaptic transmission and intrinsic neuronal excitability in mouse visual cortex in vitro.
Marongiu D; Imbrosci B; Mittmann T
Eur J Pharmacol; 2013 Jun; 709(1-3):64-71. PubMed ID: 23567067
[TBL] [Abstract][Full Text] [Related]
15. Taste memory trace disruption by AP5 administration in basolateral amygdala.
Traverso LM; Quintero E; Vargas JP; De la Casa LG; Lopez JC
Neuroreport; 2010 Jan; 21(2):99-103. PubMed ID: 19952967
[TBL] [Abstract][Full Text] [Related]
16. Amygdaloid metabotropic glutamate receptor subtype 7 is involved in the acquisition of conditioned fear.
Siegl S; Flor PJ; Fendt M
Neuroreport; 2008 Jul; 19(11):1147-50. PubMed ID: 18596617
[TBL] [Abstract][Full Text] [Related]
17. The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases.
Koszła O; Sołek P; Woźniak S; Kędzierska E; Wróbel TM; Kondej M; Archała A; Stępnicki P; Biała G; Matosiuk D; Kaczor AA
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238370
[TBL] [Abstract][Full Text] [Related]
18. Neurogenesis as a potential therapeutic strategy for neurodegenerative disorders.
Kelleher-Andersson J
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S19-25. PubMed ID: 15665409
[No Abstract] [Full Text] [Related]
19. Learning and memory in conditioned fear extinction: effects of D-cycloserine.
Vervliet B
Acta Psychol (Amst); 2008 Mar; 127(3):601-13. PubMed ID: 17707326
[TBL] [Abstract][Full Text] [Related]
20. Running exercise delays neurodegeneration in amygdala and hippocampus of Alzheimer's disease (APP/PS1) transgenic mice.
Lin TW; Shih YH; Chen SJ; Lien CH; Chang CY; Huang TY; Chen SH; Jen CJ; Kuo YM
Neurobiol Learn Mem; 2015 Feb; 118():189-97. PubMed ID: 25543023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
